The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

As managed care pharmacy navigates rapid transformations in policies, high-cost drug strategies, and innovative therapies, ...

Billionaire entrepreneur Mark Cuban in an interview with The Hill said he is hopeful the Trump administration will move to ...

President Donald Trump’s allies are resurfacing a proposal from the first Trump administration that would dramatically cut ...

Eli Lilly CEO David Ricks reveals that developing a new drug costs around $4 billion before marketing. In an exclusive ...

SaveHealth reports on the third-party companies that work to negotiate discounts with pharmacies and pharmacy benefit ...

Act" was unveiled by a group of bipartisan lawmakers Tuesday, aimed at reforming the incentive structure for Pharmacy Benefit ...

A group of former Wells Fargo employees failed to prove the bank neglected its fiduciary duties over its health plan’s ...

Employees filing pioneering suits against companies like JPMorgan Chase & Co. and Johnson & Johnson over prescription drug ...

On March 6, 2025, the Patented Medicine Prices Review Board (PMPRB) announced that Thomas Digby stepped down from his role as ...

The bill, which encompasses the recommendations of a task force, would regulate pharmacy benefit managers and increase price ...

The growing prevalence of ultrahigh-cost drugs under development is prompting health systems nationwide to rethink strategies ...